Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

MLA

Pier Luigi, Zinzani, et al. “Bortezomib as Salvage Treatment for Heavily Pretreated Relapsed Lymphoma Patients: A Multicenter Retrospective Study.” Hematological Oncology, vol. 31, no. 4, June 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8df89fda883275e65f4002dd5dc71c4e&authtype=sso&custid=ns315887.

APA

Pier Luigi, Z., Cinzia, P., Emanuela, M., Filippo, B., Alberto, F., Attilio, G., Vincenzo, P., Gerlando, Q., Benedetta, P., Maria Luigia, V., Vittorio, S., Enrico, D., Alessandro, B., Letizia, G., Federica, Q., Beatrice, C., Lisa, A., & Michele, B. (2012). Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study. Hematological Oncology, 31(4).

Chicago

Pier Luigi, Zinzani, Pellegrini Cinzia, Merla Emanuela, Ballerini Filippo, Fabbri Alberto, Guarini Attilio, Pavone Vincenzo, et al. 2012. “Bortezomib as Salvage Treatment for Heavily Pretreated Relapsed Lymphoma Patients: A Multicenter Retrospective Study.” Hematological Oncology 31 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8df89fda883275e65f4002dd5dc71c4e&authtype=sso&custid=ns315887.